Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc Displacement

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 8, 2008, Pages 1644-1651

  Kurtoglu, Cem ^a   Gur, Osman Hayri ^b   Kurkcu, Mehmet ^a   Sertdemir, Yasar ^a   Guler Uysal, Fusun ^a   Uysal, Hakan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Faculty of Dentistry and Currently   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; HUMAN; INFORMED CONSENT; MALE; MASSETER MUSCLE; MUSCLE ACTION POTENTIAL; MYOFASCIAL PAIN; PAIN ASSESSMENT; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TEMPORALIS MUSCLE; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME;

ACTION POTENTIALS; ADOLESCENT; ADULT; BOTULINUM TOXIN TYPE A; DEPRESSION; DISLOCATIONS; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MASSETER MUSCLE; MIDDLE AGED; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; TEMPORAL MUSCLE; TEMPOROMANDIBULAR JOINT DISK; TEMPOROMANDIBULAR JOINT DISORDERS; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;

EID: 47049092721     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.03.008     Document Type: Article

References (30)

1. Okeson J.P. Orofacial Pain: Guidelines for Assessment, Diagnosis and Management (1996), Quintessence Co, Chicago 45-52
2. Dworkin S.F., and LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain 6 (1992) 301
3. Davies S.J., and Gray R.J. The pattern of splint usage in the management of two common temporomandibular disorders. Part II: The stabilisation splint in the treatment of pain dysfunction syndrome. Br Dent J 183 (1997) 247
4. Garefis P., Grigoriadou E., Zarifi A., et al. Effectiveness of conservative treatment for craniomandibular disorders: A 2-year longtidunal study. J Orofac Pain 8 (1994) 309
5. Bentsianov B., Zalvan C., and Blitzer A. Noncosmetic uses of botulinum toxin. Clin Dermatol 22 (2004) 82
6. Poewe W., Deuschl G., Nebe A., et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia: Results of a double blind, placebo controlled, dose ranging study using Dysport. The German Dystonia Study Group-GDSG. J Neurol Neurosurg Psychiatry 64 (1998) 13
7. Freund B., Schwartz M., and Symington J.M. Botulinum toxin: New treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 38 (2000) 466
8. Freund B., Schwartz M., and Symington J.M. The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings. J Oral Maxillofac Surg 57 (1999) 916
9. Tan E.K., and Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131 (2000) 211
10. To E.W., Ahuja A.T., and Ho W.S. A prospective study of the effect of botulinum toxin on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 54 (2001) 197
11. Altman D.G., Schulz K.F., Moher D., et al., CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134 (2001) 663
12. Landulpho A.B., Silva W.A., Silva F.A., et al. Electromyographic evaluation of masseter and anterior temporalis muscles in patients with temporomandibular disorders following interocclusal appliance treatment. J Oral Rehabil 31 (2004) 95
13. Schwartz M., and Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 18 (2002) 198
14. LeResche L. Assessment of physical and behavioral outcomes of treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 82
15. Okeson J.P. Management of Temporomandibular Disorders and Occlusion. ed 5 (2003), Mosby, St Louis, MO
16. Pullman S.L., Goodin D.S., Marquinez A.I., et al. Clinical utility of surface EMG: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 171
17. Cooper B.C. The role of bioelectronic instrumentation in the documentation and management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 91
18. Lund J.P., and Widmer C.G. Evaluation of the use of surface electromyography in the diagnosis, documentation and treatment of dental patients. J Craniomandib Disord 3 (1989) 125
19. Manns A., Miralles R., and Guerrer F. The changes in electrical activity of the postural muscles of mandible upon varying the vertical dimension. J Prosthet Dent 45 (1981) 438
20. Watkinson A.C. The mandibular rest position and electromyography-A review. J Oral Rehabil 14 (1987) 209
21. Mohamed S.E., and Christensen L.V. Mandibular reference positions. J Oral Rehabil 12 (1985) 355
22. Mohl N.D., Lund J.P., Widmer C.G., et al. Devices for the diagnosis and treatment of temporomandibular disorders. Part II: Electromyography and sonography. J Prosthet Dent 63 (1990) 332
23. Nixdorf D.R., Heo G., and Major P.W. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain 99 (2002) 465
24. Holmgren K., Sheikholeslam A., Riise C., et al. The effects of an occlusal splint on the electromyographic activities of the temporal and masseter muscles during maximal clenching in patients with a habit of nocturnal bruxism and signs and symptoms of craniomandibular disorders. J Oral Rehabil 17 (1990) 447
25. Abekura H., Kotani H., Tokuyama H., et al. Asymmetry of masticatory muscle activity during intercuspal maximal clenching in healthy subjects and subjects with stomatognathic dysfunction syndrome. J Oral Rehabil 22 (1995) 699
26. Tesch R.S., Denardin O.V., Baptista C.A., et al. Depression levels in chronic pain patients: A pilot study. J Oral Rehabil 31 (2004) 926
27. Conti P.C., de Azevedo L.R., de Souza N.V., et al. Pain measurement in TMD patients: Evaluation of precision and sensitivity of different scales. J Oral Rehabil 28 (2001) 534
28. Dworkin S.F. A model for pain mechanisms in myogenous temporomandibular disorders. Pain Forum 6 (1997) 166
29. Freund B., and Schwartz M. Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain 4 (2003) 159
30. von Lindern J.J., Niederhagen B., Berge S., et al. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 61 (2003) 774